Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Total 10000 results

Swiss Group for Clinical Cancer Research

Completed

Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

Switzerland
Hospital San Carlos, Madrid
Complexo Hospitalario Universitario de A Coruña

Completed

Standard Versus Continuous Capecitabine in Advanced Breast Cancer

Metastatic Breast Cancer

Spain
Bayer

Completed

Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor (RESPITE)

Hypertension, Pulmonary

Belgium, United States, Switzerland, Canada, France, Germany, Italy, United Kingdom, Czechia
Zhejiang Cancer Hospital

Unknown

Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy (CALORIE)

Breast Cancer
Eisai Inc.
Eisai Co., Ltd.

Completed

Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary Embolism

Pulmonary Embolism

Japan
American College of Radiology Imaging Network
National Cancer Institute (NCI)

Terminated

FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy (ACRIN6678)

Lung Cancer

United States
Asan Medical Center

Unknown

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

Cancer | Lung Cancer Metastatic | Immunotherapy

Korea, Republic of
University Hospital, Limoges

Terminated

Cardiopulmonary Effects of Bronchoalveolar Wash on Patients With Acute Respiratory Distress Syndrome (FLOOD)

Bronchioalveolar Lavage

France
Qilu Pharmaceutical Co., Ltd.

Unknown

A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition (Capecitabine)

Breast Cancer | Colon Cancer
John Mark Sloan
Gilead Sciences

Terminated

Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis

Amyloidosis

United States
Hennepin Healthcare Research Institute
Aventis Pharmaceuticals

Completed

The Use of Low Molecular Weight Heparin in Traumatic Brain Injury

Brain Injury | Venous Thrombosis

United States
The Catholic University of Korea

Unknown

Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer

Stomach Neoplasms

Korea, Republic of
Bayer

Completed

A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice (CAPTURE)

Hypertension, Pulmonary

Japan, Germany, Sweden, Colombia, Turkey, Belgium, Canada
Samsung Medical Center
Roche Pharma AG

Terminated

Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Korea, Republic of
GlaxoSmithKline

Completed

A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848

Atherosclerosis

United States
Hoffmann-La Roche

Completed

A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

Bulgaria
West China Hospital

Unknown

Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery

Thoracic Surgery | Thromboprophylaxis

China
Chromaderm, Inc.

Completed

Reduction in the Occurrence of Center-Involved Diabetic Macular Edema

Diabetic Retinopathy

United States, Canada, France, Denmark, Australia, Netherlands, Taiwan, Spain, Italy, Germany, Portugal, United Kingdom, Russian Federation, Poland, India, Brazil, Mexico
Chromaderm, Inc.

Completed

Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Capecitabine in Treating Patients With Malignant Mesothelioma

Malignant Mesothelioma

United States
Mirati Therapeutics Inc.

Terminated

Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Hodgkin's Lymphoma

United States, Canada
Mirati Therapeutics Inc.

Completed

Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma

Lymphoma

United States, Canada
Indiana University School of Medicine
Genzyme, a Sanofi Company

Completed

A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT

Hematologic Malignancies

United States
University of Liverpool
Liverpool University Hospitals NHS Foundation Trust

Completed

Dose Response Study of Nitisinone in Alkaptonuria (SONIA1)

Alkaptonuria

United Kingdom
National Cancer Institute (NCI)

Completed

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Recurrent Melanoma | Stage IV Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA Melanoma

United States
ThromboGenics

Completed

Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion (MIVI-8)

Focal Vitreomacular Adhesion

Belgium
University of Chicago
Genzyme, a Sanofi Company

Completed

Clofarabine Bone Marrow Cytoreduction

Leukemia

United States
Sun Yat-sen University

Unknown

Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer (CAMCO)

Colorectal Neoplasms

China
Harbin Medical University

Unknown

Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer

Rectal Cancer

China
Boehringer Ingelheim

Terminated

Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial

Heart Arrest

Germany, Belgium, Sweden, France, Austria, Italy, Norway, Spain, Switzerland
Dr. Sidney Ben Chetrit

Unknown

Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.

Hemodialysis Patients

Israel
Cambridge University Hospitals NHS Foundation Trust

Completed

Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery

Melanoma (Skin)

United Kingdom
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Cervical Cancer

United States, Norway
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Fudan University

Unknown

A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics

Solid Tumor

China
Pfizer

Terminated

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Advanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)

United States, Spain, Hong Kong, Belgium, Australia, France
National University Hospital, Singapore

Completed

Study of Capecitabine In Patients With Solid Tumors

Solid Tumors

Singapore
Tianjin Medical University

Unknown

Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer

Breast Cancer

China
University of North Carolina, Chapel Hill
National Center for Research Resources (NCRR); Doris Duke Charitable Foundation

Completed

Efficacy of Cantharidin in Molluscum Contagiosum

Molluscum Contagiosum, Skin Disease

United States
Genentech, Inc.

Completed

A Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters (TROPICS 2)

Dysfunctional Central Venous Access Catheters
Sanofi

Completed

Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)

Thrombosis

France
General Hospital of Chalkida

Unknown

Bosentan for Severe Mitral Valve Dysfunction (BOSMIVAR)

SECONDARY PULMONARY HYPERTENSION | MITRAL STENOSIS | CHILDHOOD RHEUMATOID FEVER | CONGESTIVE HEART FAILURE

Greece
Institute of Oncology Ljubljana

Completed

Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer

Resectable Rectal Cancer Clinical Stage II and III

Slovenia
Solvay Pharmaceuticals

Completed

Effects of Fenofibrate on Gene Expression in Healthy Volunteers

Healthy

United Kingdom
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Completed

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors

United States
Rikshospitalet University Hospital

Terminated

Treatment of Early Systemic Sclerosis by Bosentan (TRANOS)

Systemic Sclerosis (Scleroderma)

Norway
Radboud University Medical Center

Completed

Effect of Selective iNOS Inhibition During Human Endotoxemia

Endotoxemia

Netherlands
Shanghai Zhongshan Hospital

Not yet recruiting

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer | Chemotherapy Effect
Erasmus Medical Center

Not yet recruiting

The Value of 68Ga-FAPI PET/CT for Evaluating Peritoneal Treatment Response (INTERACT-FAPI)

Peritoneal Metastasis | FAPI
Foundation University Islamabad

Recruiting

Effect of Action Observation Therapy in Comparison to Motor Relearning Program on Balance and Mobility Among Subacute Stroke Patients

Cerebral Stroke | Functional Performance | Cerebrovascular Stroke | Posture | Subacute Stroke

Pakistan
Pfizer

Recruiting

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

Dermatitis, Atopic | Atopic Dermatitis | Atopic Dermatitis, Unspecified

United States

Search clinical trials for: ACTIVA BioACTIVE-RESTORATIVE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations